nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Arrhythmia—Cisplatin—urinary bladder cancer	0.00272	0.00272	CcSEcCtD
Flumazenil—Abnormal vision—Epirubicin—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Flumazenil—Tachycardia—Thiotepa—urinary bladder cancer	0.00269	0.00269	CcSEcCtD
Flumazenil—Erythema—Cisplatin—urinary bladder cancer	0.00265	0.00265	CcSEcCtD
Flumazenil—Ill-defined disorder—Gemcitabine—urinary bladder cancer	0.00264	0.00264	CcSEcCtD
Flumazenil—Vision blurred—Fluorouracil—urinary bladder cancer	0.00263	0.00263	CcSEcCtD
Flumazenil—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.00261	0.00261	CcSEcCtD
Flumazenil—Flushing—Etoposide—urinary bladder cancer	0.00259	0.00259	CcSEcCtD
Flumazenil—Malaise—Gemcitabine—urinary bladder cancer	0.00256	0.00256	CcSEcCtD
Flumazenil—Abnormal vision—Doxorubicin—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Flumazenil—Chills—Etoposide—urinary bladder cancer	0.0025	0.0025	CcSEcCtD
Flumazenil—Vision blurred—Cisplatin—urinary bladder cancer	0.00249	0.00249	CcSEcCtD
Flumazenil—Tremor—Cisplatin—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Flumazenil—Cough—Gemcitabine—urinary bladder cancer	0.00248	0.00248	CcSEcCtD
Flumazenil—Paraesthesia—Thiotepa—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Flumazenil—Ill-defined disorder—Cisplatin—urinary bladder cancer	0.00246	0.00246	CcSEcCtD
Flumazenil—Hypertension—Gemcitabine—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Flumazenil—Somnolence—Thiotepa—urinary bladder cancer	0.00245	0.00245	CcSEcCtD
Flumazenil—Chest pain—Gemcitabine—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Flumazenil—Hot flush—Epirubicin—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Flumazenil—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Flumazenil—Menopausal symptoms—Epirubicin—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Flumazenil—Discomfort—Gemcitabine—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Flumazenil—Malaise—Cisplatin—urinary bladder cancer	0.00239	0.00239	CcSEcCtD
Flumazenil—Chest pain—Fluorouracil—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Flumazenil—Fatigue—Thiotepa—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Flumazenil—Pain—Thiotepa—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Flumazenil—Discomfort—Fluorouracil—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Flumazenil—Confusional state—Fluorouracil—urinary bladder cancer	0.0023	0.0023	CcSEcCtD
Flumazenil—Mood swings—Methotrexate—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Flumazenil—Feeling abnormal—Thiotepa—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Flumazenil—Ataxia—Methotrexate—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Flumazenil—Diplopia—Epirubicin—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Flumazenil—Ill-defined disorder—Etoposide—urinary bladder cancer	0.00225	0.00225	CcSEcCtD
Flumazenil—Anxiety—Cisplatin—urinary bladder cancer	0.00225	0.00225	CcSEcCtD
Flumazenil—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Flumazenil—Hot flush—Doxorubicin—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Flumazenil—Discomfort—Cisplatin—urinary bladder cancer	0.00223	0.00223	CcSEcCtD
Flumazenil—Tachycardia—Fluorouracil—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Flumazenil—Affect lability—Epirubicin—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Flumazenil—Menopausal symptoms—Doxorubicin—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Flumazenil—Urticaria—Thiotepa—urinary bladder cancer	0.00219	0.00219	CcSEcCtD
Flumazenil—Malaise—Etoposide—urinary bladder cancer	0.00219	0.00219	CcSEcCtD
Flumazenil—Vertigo—Etoposide—urinary bladder cancer	0.00218	0.00218	CcSEcCtD
Flumazenil—Hypotension—Gemcitabine—urinary bladder cancer	0.00217	0.00217	CcSEcCtD
Flumazenil—Mood swings—Epirubicin—urinary bladder cancer	0.00214	0.00214	CcSEcCtD
Flumazenil—Hypotension—Fluorouracil—urinary bladder cancer	0.00213	0.00213	CcSEcCtD
Flumazenil—Ataxia—Epirubicin—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Flumazenil—Cough—Etoposide—urinary bladder cancer	0.00212	0.00212	CcSEcCtD
Flumazenil—Tachycardia—Cisplatin—urinary bladder cancer	0.00211	0.00211	CcSEcCtD
Flumazenil—Insomnia—Gemcitabine—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Flumazenil—Hypertension—Etoposide—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Flumazenil—Diplopia—Doxorubicin—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Flumazenil—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Flumazenil—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Flumazenil—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00207	0.00207	CcSEcCtD
Flumazenil—Chest pain—Etoposide—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Flumazenil—Insomnia—Fluorouracil—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Flumazenil—Somnolence—Gemcitabine—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Flumazenil—Affect lability—Doxorubicin—urinary bladder cancer	0.00206	0.00206	CcSEcCtD
Flumazenil—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00205	0.00205	CcSEcCtD
Flumazenil—Discomfort—Etoposide—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Flumazenil—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Flumazenil—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Flumazenil—Somnolence—Fluorouracil—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Flumazenil—Hypotension—Cisplatin—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Flumazenil—Fatigue—Gemcitabine—urinary bladder cancer	0.002	0.002	CcSEcCtD
Flumazenil—Confusional state—Etoposide—urinary bladder cancer	0.002	0.002	CcSEcCtD
Flumazenil—Pain—Gemcitabine—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Flumazenil—Mood swings—Doxorubicin—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Flumazenil—Asthenia—Thiotepa—urinary bladder cancer	0.00198	0.00198	CcSEcCtD
Flumazenil—Ataxia—Doxorubicin—urinary bladder cancer	0.00196	0.00196	CcSEcCtD
Flumazenil—Pruritus—Thiotepa—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Flumazenil—Pain—Fluorouracil—urinary bladder cancer	0.00195	0.00195	CcSEcCtD
Flumazenil—Paraesthesia—Cisplatin—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Flumazenil—Tachycardia—Etoposide—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Flumazenil—Dyspnoea—Cisplatin—urinary bladder cancer	0.00193	0.00193	CcSEcCtD
Flumazenil—Hyperhidrosis—Etoposide—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Flumazenil—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Flumazenil—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Flumazenil—Drowsiness—Methotrexate—urinary bladder cancer	0.00186	0.00186	CcSEcCtD
Flumazenil—Hypotension—Etoposide—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Flumazenil—Pain—Cisplatin—urinary bladder cancer	0.00185	0.00185	CcSEcCtD
Flumazenil—Dizziness—Thiotepa—urinary bladder cancer	0.00182	0.00182	CcSEcCtD
Flumazenil—Urticaria—Fluorouracil—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Flumazenil—Sweating—Methotrexate—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Flumazenil—Feeling abnormal—Cisplatin—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Flumazenil—Paraesthesia—Etoposide—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Flumazenil—Dyspnoea—Etoposide—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Flumazenil—Somnolence—Etoposide—urinary bladder cancer	0.00176	0.00176	CcSEcCtD
Flumazenil—Vomiting—Thiotepa—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Flumazenil—Drowsiness—Epirubicin—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Flumazenil—Rash—Thiotepa—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Flumazenil—Dermatitis—Thiotepa—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Flumazenil—Headache—Thiotepa—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Flumazenil—Fatigue—Etoposide—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Flumazenil—Pain—Etoposide—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Flumazenil—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Flumazenil—Sweating—Epirubicin—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Flumazenil—Asthenia—Gemcitabine—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Flumazenil—Pruritus—Gemcitabine—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Flumazenil—Nausea—Thiotepa—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Flumazenil—Feeling abnormal—Etoposide—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Flumazenil—Pruritus—Fluorouracil—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Flumazenil—Drowsiness—Doxorubicin—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Flumazenil—Visual impairment—Methotrexate—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Flumazenil—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Flumazenil—Bradycardia—Epirubicin—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Flumazenil—Urticaria—Etoposide—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Flumazenil—Tinnitus—Methotrexate—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Flumazenil—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Flumazenil—Asthenia—Cisplatin—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Flumazenil—Sweating—Doxorubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Flumazenil—Dizziness—Fluorouracil—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Flumazenil—Visual impairment—Epirubicin—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Flumazenil—Chills—Methotrexate—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Flumazenil—Vomiting—Gemcitabine—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Flumazenil—Bradycardia—Doxorubicin—urinary bladder cancer	0.00147	0.00147	CcSEcCtD
Flumazenil—Rash—Gemcitabine—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Flumazenil—Dermatitis—Gemcitabine—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Flumazenil—Hypersensitivity—Etoposide—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Flumazenil—Tinnitus—Epirubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Flumazenil—Erythema—Methotrexate—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Flumazenil—Headache—Gemcitabine—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Flumazenil—Flushing—Epirubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Flumazenil—Vomiting—Fluorouracil—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Flumazenil—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Flumazenil—Rash—Fluorouracil—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Flumazenil—Dermatitis—Fluorouracil—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Flumazenil—Headache—Fluorouracil—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Flumazenil—Asthenia—Etoposide—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Flumazenil—Chills—Epirubicin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Flumazenil—Pruritus—Etoposide—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Flumazenil—Arrhythmia—Epirubicin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Flumazenil—Visual impairment—Doxorubicin—urinary bladder cancer	0.00139	0.00139	CcSEcCtD
Flumazenil—Nausea—Gemcitabine—urinary bladder cancer	0.00138	0.00138	CcSEcCtD
Flumazenil—Vomiting—Cisplatin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Flumazenil—Vision blurred—Methotrexate—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Flumazenil—Rash—Cisplatin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Flumazenil—Dermatitis—Cisplatin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Flumazenil—Erythema—Epirubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Flumazenil—Nausea—Fluorouracil—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Flumazenil—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Flumazenil—Tinnitus—Doxorubicin—urinary bladder cancer	0.00135	0.00135	CcSEcCtD
Flumazenil—Flushing—Doxorubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Flumazenil—Tension—Epirubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Flumazenil—Nervousness—Epirubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Flumazenil—Malaise—Methotrexate—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Flumazenil—Dizziness—Etoposide—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Flumazenil—Vertigo—Methotrexate—urinary bladder cancer	0.00131	0.00131	CcSEcCtD
Flumazenil—Chills—Doxorubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Flumazenil—Arrhythmia—Doxorubicin—urinary bladder cancer	0.00129	0.00129	CcSEcCtD
Flumazenil—Nausea—Cisplatin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Flumazenil—Vision blurred—Epirubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Flumazenil—Cough—Methotrexate—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Flumazenil—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Flumazenil—Vomiting—Etoposide—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Flumazenil—Erythema—Doxorubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Flumazenil—Agitation—Epirubicin—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Flumazenil—Rash—Etoposide—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Flumazenil—Dermatitis—Etoposide—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Flumazenil—Headache—Etoposide—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Flumazenil—Chest pain—Methotrexate—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Flumazenil—Tension—Doxorubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Flumazenil—Malaise—Epirubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Flumazenil—Discomfort—Methotrexate—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Flumazenil—Nervousness—Doxorubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Flumazenil—Vertigo—Epirubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Flumazenil—Palpitations—Epirubicin—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Flumazenil—Confusional state—Methotrexate—urinary bladder cancer	0.0012	0.0012	CcSEcCtD
Flumazenil—Cough—Epirubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Flumazenil—Vision blurred—Doxorubicin—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Flumazenil—Nausea—Etoposide—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Flumazenil—Hypertension—Epirubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Flumazenil—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Flumazenil—Chest pain—Epirubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Flumazenil—Agitation—Doxorubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Flumazenil—Anxiety—Epirubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Flumazenil—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Flumazenil—Discomfort—Epirubicin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Flumazenil—Malaise—Doxorubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Flumazenil—Dry mouth—Epirubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Flumazenil—Vertigo—Doxorubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Flumazenil—Confusional state—Epirubicin—urinary bladder cancer	0.00112	0.00112	CcSEcCtD
Flumazenil—Palpitations—Doxorubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Flumazenil—Hypotension—Methotrexate—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Flumazenil—Cough—Doxorubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Flumazenil—Hypertension—Doxorubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Flumazenil—Tachycardia—Epirubicin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Flumazenil—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Flumazenil—Insomnia—Methotrexate—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Flumazenil—Chest pain—Doxorubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Flumazenil—Anxiety—Doxorubicin—urinary bladder cancer	0.00107	0.00107	CcSEcCtD
Flumazenil—Paraesthesia—Methotrexate—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Flumazenil—Discomfort—Doxorubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Flumazenil—Dyspnoea—Methotrexate—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Flumazenil—Somnolence—Methotrexate—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Flumazenil—Dry mouth—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Flumazenil—Hypotension—Epirubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Flumazenil—Confusional state—Doxorubicin—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Flumazenil—Fatigue—Methotrexate—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Flumazenil—Pain—Methotrexate—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Flumazenil—Insomnia—Epirubicin—urinary bladder cancer	0.001	0.001	CcSEcCtD
Flumazenil—Tachycardia—Doxorubicin—urinary bladder cancer	0.001	0.001	CcSEcCtD
Flumazenil—Paraesthesia—Epirubicin—urinary bladder cancer	0.000996	0.000996	CcSEcCtD
Flumazenil—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000992	0.000992	CcSEcCtD
Flumazenil—Dyspnoea—Epirubicin—urinary bladder cancer	0.000989	0.000989	CcSEcCtD
Flumazenil—Somnolence—Epirubicin—urinary bladder cancer	0.000986	0.000986	CcSEcCtD
Flumazenil—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000977	0.000977	CcSEcCtD
Flumazenil—Hypotension—Doxorubicin—urinary bladder cancer	0.000959	0.000959	CcSEcCtD
Flumazenil—Fatigue—Epirubicin—urinary bladder cancer	0.000957	0.000957	CcSEcCtD
Flumazenil—Pain—Epirubicin—urinary bladder cancer	0.000949	0.000949	CcSEcCtD
Flumazenil—Urticaria—Methotrexate—urinary bladder cancer	0.000942	0.000942	CcSEcCtD
Flumazenil—Insomnia—Doxorubicin—urinary bladder cancer	0.000928	0.000928	CcSEcCtD
Flumazenil—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000922	0.000922	CcSEcCtD
Flumazenil—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000915	0.000915	CcSEcCtD
Flumazenil—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000914	0.000914	CcSEcCtD
Flumazenil—Somnolence—Doxorubicin—urinary bladder cancer	0.000913	0.000913	CcSEcCtD
Flumazenil—Fatigue—Doxorubicin—urinary bladder cancer	0.000885	0.000885	CcSEcCtD
Flumazenil—Urticaria—Epirubicin—urinary bladder cancer	0.000881	0.000881	CcSEcCtD
Flumazenil—Pain—Doxorubicin—urinary bladder cancer	0.000878	0.000878	CcSEcCtD
Flumazenil—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000873	0.000873	CcSEcCtD
Flumazenil—Asthenia—Methotrexate—urinary bladder cancer	0.000851	0.000851	CcSEcCtD
Flumazenil—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000846	0.000846	CcSEcCtD
Flumazenil—Pruritus—Methotrexate—urinary bladder cancer	0.000839	0.000839	CcSEcCtD
Flumazenil—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000817	0.000817	CcSEcCtD
Flumazenil—Urticaria—Doxorubicin—urinary bladder cancer	0.000816	0.000816	CcSEcCtD
Flumazenil—Asthenia—Epirubicin—urinary bladder cancer	0.000796	0.000796	CcSEcCtD
Flumazenil—Pruritus—Epirubicin—urinary bladder cancer	0.000785	0.000785	CcSEcCtD
Flumazenil—Dizziness—Methotrexate—urinary bladder cancer	0.000784	0.000784	CcSEcCtD
Flumazenil—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000756	0.000756	CcSEcCtD
Flumazenil—Vomiting—Methotrexate—urinary bladder cancer	0.000754	0.000754	CcSEcCtD
Flumazenil—Rash—Methotrexate—urinary bladder cancer	0.000748	0.000748	CcSEcCtD
Flumazenil—Dermatitis—Methotrexate—urinary bladder cancer	0.000747	0.000747	CcSEcCtD
Flumazenil—Headache—Methotrexate—urinary bladder cancer	0.000743	0.000743	CcSEcCtD
Flumazenil—Asthenia—Doxorubicin—urinary bladder cancer	0.000737	0.000737	CcSEcCtD
Flumazenil—Dizziness—Epirubicin—urinary bladder cancer	0.000734	0.000734	CcSEcCtD
Flumazenil—Pruritus—Doxorubicin—urinary bladder cancer	0.000726	0.000726	CcSEcCtD
Flumazenil—Vomiting—Epirubicin—urinary bladder cancer	0.000705	0.000705	CcSEcCtD
Flumazenil—Nausea—Methotrexate—urinary bladder cancer	0.000704	0.000704	CcSEcCtD
Flumazenil—Rash—Epirubicin—urinary bladder cancer	0.0007	0.0007	CcSEcCtD
Flumazenil—Dermatitis—Epirubicin—urinary bladder cancer	0.000699	0.000699	CcSEcCtD
Flumazenil—Headache—Epirubicin—urinary bladder cancer	0.000695	0.000695	CcSEcCtD
Flumazenil—Dizziness—Doxorubicin—urinary bladder cancer	0.000679	0.000679	CcSEcCtD
Flumazenil—Nausea—Epirubicin—urinary bladder cancer	0.000659	0.000659	CcSEcCtD
Flumazenil—Vomiting—Doxorubicin—urinary bladder cancer	0.000653	0.000653	CcSEcCtD
Flumazenil—Rash—Doxorubicin—urinary bladder cancer	0.000647	0.000647	CcSEcCtD
Flumazenil—Dermatitis—Doxorubicin—urinary bladder cancer	0.000647	0.000647	CcSEcCtD
Flumazenil—Headache—Doxorubicin—urinary bladder cancer	0.000643	0.000643	CcSEcCtD
Flumazenil—Nausea—Doxorubicin—urinary bladder cancer	0.00061	0.00061	CcSEcCtD
